Skip to main content
. 2021 Dec 17;23(2):51. doi: 10.3892/ol.2021.13169

Figure 3.

Figure 3.

CD155 and CD112 mRNA expression is downregulated by FLT3 inhibitors in acute myeloid leukemia cells with FLT3 mutations. CD155 and CD112 mRNA expression levels in MOLM-13 and MV-4-11 cells exposed to FLT3 inhibitors (quizartinib or gilteritinib). Experiments were performed in triplicate. Data were statistically analyzed using the one-tailed unpaired t-test. *P<0.05. 18S rRNA, 18S ribosomal RNA; FLT3, FMS-like tyrosine kinase 3; NS, no significant difference.